NEU 2.81% $18.65 neuren pharmaceuticals limited

retts syndrome, page-27

  1. 2,647 Posts.
    lightbulb Created with Sketch. 432
    TI and ST,

    sorry I'm being unclear in my choice of language so let me clarify.

    As you say they already have fast track designation so it would maybe better to say "we know they aim to use their fast track designation" or some such. That's not a lot clearer but I think you see what I mean.

    However wizza's point was that they might finish the Phase II early and that would surprise me.

    So in summary what I'm saying is: I'm expecting the phase trial to run its full length to March/ April. If the results are compelling they will push that fast track as hard as they can.

    And yes roll on that Fragile X fast track. I hope it's a fait accompli given they got the Rett one but it will still be nice to have on record.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.